SyvekRadial™ Patch promotes control of bleeding from radial access sites through the use of poly-N-acetyl glucosamine (pGlcNAc) fibers derived from microalgae. These fibers effectively control bleeding for patients on anticoagulation therapies.3
The SyvekRadial™ system consists of three components:
The SyvekRadial™ Band bladder is designed to target the radial artery only, preserving ulnar artery patency.
The standard of care post-procedure for transradial access has been prolonged manual compression (2-6 hours). A U.S. trial studied the effects of using the pGlcNAc fibers found in the SyvekRadial™ Patch to facilitate shorter compression times in 50 patients. The first 15 patients acted as a roll-in group for device and procedure standardization. The remaining 35 were assigned to the compression group for diagnostic (n=26) and interventional procedures (n=9). Patients were randomized to 10, 30, or 60 minute compression times.1
Indications for Use:
Syvek® Patch promotes the rapid control of bleeding in patients following hemodialysis and in patients on anticoagulation therapy. Syvek® Patch is indicated for use in the local management of bleeding wounds such as vascular access site, percutaneous catheters or tubes and surgical debridement. Syvek® Patch is intended for use under the direction of a healthcare professional.
PRECAUTIONS: There are no known contraindications to the use of Syvek® Patch. Longer compression may be necessary for patients who are hypertensive or who are obese. For external use only.
Not made with Natural Rubber Latex
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician or other licensed practitioner. For external use only.
Manufactured by Marine Polymer Technologies, Inc., Danvers, MA 01923. For instructions for use or additional product information, please contact us.
*Please see the “Instructions for Use” supplied in each package, for detailed product instructions.